Literature DB >> 1305026

Possible relation between HLA and ABO type and prognosis of uveal melanoma.

M J Jager1, H J Völker-Dieben, D de Wolff-Rouendaal, H Kakebeeke-Kemme, J D'Amaro.   

Abstract

Not only local parameters but also genetic determinants like the HLA genes may play a role in the development and clinical behavior of malignant tumors. In skin melanoma the presence of HLA-B40 is associated with a poor prognosis. We tested the hypothesis that the clinical behavior of uveal melanoma is influenced by the HLA type of the patient. The HLA types of 44 patients with uveal melanoma had been determined before operation with a view to using the cornea of the enucleated eye for an HLA-matched corneal transplantation. We compared the ABO and HLA types of the patients with the development of metastases and with the ten-year patient survival. An association was observed between the presence of HLA-B40 and death due to metastasis of uveal melanoma. We conclude that the HLA type of the patient may influence the clinical behavior not only of skin melanoma but also of uveal melanoma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1305026     DOI: 10.1007/bf00156992

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  11 in total

1.  HL-A and ABO antigens and malignant melanoma. A study of 212 cases.

Authors:  L U Lamm; F Kissmeyer-Nielsen; K E Kjerbye; B Morgensen; N C Petersen
Journal:  Cancer       Date:  1974-05       Impact factor: 6.860

2.  [HLA-antigens in eye diseases (author's transl)].

Authors:  B Dieckhues; G Jünemann; H J Küchle; T Püttmann
Journal:  Klin Monbl Augenheilkd       Date:  1979-11       Impact factor: 0.700

3.  HLA and ABO antigens in malignant choroidal melanoma.

Authors:  H J Völker-Dieben; J D'Amaro; P de Lange; D W Rouendaal
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

4.  Primary choroidal and cutaneous melanomas, bilateral choroidal melanomas, and familial occurrence of melanomas.

Authors:  J A Oosterhuis; L N Went; H T Lynch
Journal:  Br J Ophthalmol       Date:  1982-04       Impact factor: 4.638

5.  Longevity and heredity in humans. Association with the human leucocyte antigen phenotype.

Authors:  A M Lagaay; J D'Amaro; G J Ligthart; G M Schreuder; J J van Rood; W Hijmans
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

6.  HLA and DR antigen frequencies in melanoma patients: possible relation to disease prognosis.

Authors:  M S Pollack; P O Livingston
Journal:  Tissue Antigens       Date:  1985-10

7.  Missing evidence for HLA antigen association with Eales' disease, chorioretinitis, central serous retinopathy, and malignant choroidal melanoma.

Authors:  J Bertrams; M Spitznas; M Rommelfanger
Journal:  Invest Ophthalmol Vis Sci       Date:  1978-09       Impact factor: 4.799

8.  [Augmentation of HL-A A9 antigen in malignant melanoma, principally in metastatic or recurrent forms. Apropos of 105 cases of melanoma of which 34 were serious forms].

Authors:  B Cavelier; M Daveau; D Gilbert; M Fontaine; J P Cesarini; B Delpech
Journal:  C R Seances Acad Sci D       Date:  1980-09-15

9.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640

10.  HLA antigens in malignant melanoma patients.

Authors:  G Pellegris; M T Illeni; M Vaglini; D Rovini; N Cascinelli; C Masserini
Journal:  Tumori       Date:  1980-02
View more
  6 in total

Review 1.  Risk factors for intraocular melanoma and occupational exposure.

Authors:  J M Lutz; I A Cree; A J Foss
Journal:  Br J Ophthalmol       Date:  1999-10       Impact factor: 4.638

2.  Ipilimumab efficacy and safety in patients with advanced melanoma: a retrospective analysis of HLA subtype from four trials.

Authors:  Jedd D Wolchok; Jeffrey S Weber; Omid Hamid; Celeste Lebbé; Michele Maio; Dirk Schadendorf; Veerle de Pril; Kevin Heller; Tai-Tsang Chen; Ramy Ibrahim; Axel Hoos; Steven J O'Day
Journal:  Cancer Immun       Date:  2010-10-20

Review 3.  Genetics of primary intraocular tumors.

Authors:  Nisha Nagarkatti-Gude; Yujuan Wang; Mohammad Javed Ali; Santosh G Honavar; Martine J Jager; Chi-Chao Chan
Journal:  Ocul Immunol Inflamm       Date:  2012-08       Impact factor: 3.070

Review 4.  Blood biomarkers for uveal melanoma.

Authors:  Pierre L Triozzi; Arun D Singh
Journal:  Future Oncol       Date:  2012-02       Impact factor: 3.674

5.  The Relationship between ABO Blood Groups and Acne Vulgaris.

Authors:  Erdinç Terzi; Belma Türsen; Pınar Dursun; Teoman Erdem; Ümit Türsen
Journal:  Saudi J Med Med Sci       Date:  2015-12-02

Review 6.  HLA Expression in Uveal Melanoma: An Indicator of Malignancy and a Modifiable Immunological Target.

Authors:  Zahra Souri; Annemijn P A Wierenga; Arend Mulder; Aart G Jochemsen; Martine J Jager
Journal:  Cancers (Basel)       Date:  2019-08-07       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.